nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupranolol—ADRB1—Endothelin Pathways—ADCY10—nephrolithiasis	0.119	0.119	CbGpPWpGaD
Bupranolol—ADRB3—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0831	0.0831	CbGpPWpGaD
Bupranolol—ADRB3—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0698	0.0698	CbGpPWpGaD
Bupranolol—ADRB3—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.0509	0.0509	CbGpPWpGaD
Bupranolol—ADRB1—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0493	0.0493	CbGpPWpGaD
Bupranolol—ADRB2—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0482	0.0482	CbGpPWpGaD
Bupranolol—ADRB1—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0414	0.0414	CbGpPWpGaD
Bupranolol—ADRB2—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0405	0.0405	CbGpPWpGaD
Bupranolol—ADRB1—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.0302	0.0302	CbGpPWpGaD
Bupranolol—ADRB2—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.0296	0.0296	CbGpPWpGaD
Bupranolol—ADRB3—G alpha (s) signalling events—PTH—nephrolithiasis	0.0263	0.0263	CbGpPWpGaD
Bupranolol—ADRB3—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.0249	0.0249	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Other—CHRM3—nephrolithiasis	0.0214	0.0214	CbGpPWpGaD
Bupranolol—ADRB3—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.016	0.016	CbGpPWpGaD
Bupranolol—ADRB1—G alpha (s) signalling events—PTH—nephrolithiasis	0.0156	0.0156	CbGpPWpGaD
Bupranolol—ADRB2—G alpha (s) signalling events—PTH—nephrolithiasis	0.0153	0.0153	CbGpPWpGaD
Bupranolol—ADRB1—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.0148	0.0148	CbGpPWpGaD
Bupranolol—ADRB2—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.0144	0.0144	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.0137	0.0137	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—RGS14—nephrolithiasis	0.0121	0.0121	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—RGS14—nephrolithiasis	0.011	0.011	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—CHRM3—nephrolithiasis	0.0105	0.0105	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—PTH—nephrolithiasis	0.00956	0.00956	CbGpPWpGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00951	0.00951	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00931	0.00931	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—DGKH—nephrolithiasis	0.00817	0.00817	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00815	0.00815	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00797	0.00797	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—ADCY10—nephrolithiasis	0.00763	0.00763	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—DGKH—nephrolithiasis	0.00742	0.00742	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—RGS14—nephrolithiasis	0.00718	0.00718	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—RGS14—nephrolithiasis	0.00703	0.00703	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—RGS14—nephrolithiasis	0.00652	0.00652	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—RGS14—nephrolithiasis	0.00649	0.00649	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—RGS14—nephrolithiasis	0.00638	0.00638	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—CHRM3—nephrolithiasis	0.00621	0.00621	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—CHRM3—nephrolithiasis	0.00607	0.00607	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00591	0.00591	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—PTH—nephrolithiasis	0.00568	0.00568	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—PTH—nephrolithiasis	0.00555	0.00555	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—PTH—nephrolithiasis	0.00541	0.00541	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—CHRM3—nephrolithiasis	0.00537	0.00537	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—PTH—nephrolithiasis	0.00491	0.00491	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—DGKH—nephrolithiasis	0.00485	0.00485	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—DGKH—nephrolithiasis	0.00475	0.00475	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—ADCY10—nephrolithiasis	0.00453	0.00453	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—ADCY10—nephrolithiasis	0.00443	0.00443	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—DGKH—nephrolithiasis	0.00441	0.00441	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00438	0.00438	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—DGKH—nephrolithiasis	0.00438	0.00438	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—DGKH—nephrolithiasis	0.00431	0.00431	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—RGS14—nephrolithiasis	0.00385	0.00385	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—RGS14—nephrolithiasis	0.00377	0.00377	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00351	0.00351	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00343	0.00343	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—PTH—nephrolithiasis	0.00321	0.00321	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CHRM3—nephrolithiasis	0.00319	0.00319	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CHRM3—nephrolithiasis	0.00317	0.00317	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—PTH—nephrolithiasis	0.00314	0.00314	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CHRM3—nephrolithiasis	0.00312	0.00312	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—PTH—nephrolithiasis	0.00291	0.00291	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—PTH—nephrolithiasis	0.0029	0.0029	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—PTH—nephrolithiasis	0.00285	0.00285	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.0026	0.0026	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—DGKH—nephrolithiasis	0.0026	0.0026	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—DGKH—nephrolithiasis	0.00255	0.00255	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00255	0.00255	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CHRM3—nephrolithiasis	0.00188	0.00188	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CHRM3—nephrolithiasis	0.00184	0.00184	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PTH—nephrolithiasis	0.00172	0.00172	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PTH—nephrolithiasis	0.00168	0.00168	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—SPP1—nephrolithiasis	0.00146	0.00146	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—SPP1—nephrolithiasis	0.000864	0.000864	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—SPP1—nephrolithiasis	0.000845	0.000845	CbGpPWpGaD
